Shareholders Foundation, Inc.

Attention Investors Who Currently Hold NYSE:DVA Shares: DaVita HealthCare Partners Inc Under Investigation

An investigation for investors who currently hold NYSE:DVA shares was announced and DaVita HealthCare Partners Inc (NYSE:DVA) stockholders should contact the Shareholders Foundation at


San Diego, CA -- (SBWIRE) -- 09/23/2014 -- An investigation for investors, who currently hold NYSE:DVA shares, was announced concerning potential breaches of fiduciary duties by certain officers and directors of DaVita HealthCare Partners Inc, formerly DaVita Inc.

If you purchased shares of DaVita HealthCare Partners Inc (NYSE:DVA), you have certain options and you should contact the Shareholders Foundation at or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether a series of statements by DaVita HealthCare Partners Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made. More specifically, the investigation focuses whether certain DaVita HealthCare Partners officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

In July 2012, DaVita HealthCare Partners Inc announced the settlement of a Qui Tam Whistleblower Lawsuit, in connection with which the Company will pay $55million plus attorneys’ fees, resulting in a second quarter 2012 charge of $78 million.

DaVita HealthCare Partners Inc reported that its annual Total Revenue rose from over $6.21 billion in 2010 to over $11.76 billion in 2013 and that its respective Net Income rose from $405.68 million to $633.45 million. Shares of DaVita HealthCare Partners Inc (NYSE:DVA) $55.03 per share in November 2013 to as high as $75.27 per share on September 2, 2014.

Those who purchased shares of DaVita HealthCare Partners Inc (NYSE:DVA) have certain options and should contact the Shareholders Foundation.

Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739